Wells Fargo analyst Yanan Zhu maintained a Buy ... is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients’ tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback